AstraZeneca PLC (AZNCF)

1 member of Congress has disclosed 1 trade in AstraZeneca PLC (AZNCF) via STOCK Act filings. The most recent disclosure was a sale by Michael K. Simpson on 18 March 2014. Aggregate disclosed activity totals roughly $8K in sales (midpoint estimates from bracketed disclosure amounts).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Price data is not available for AZNCF
This ticker may have been delisted, renamed, or is not publicly quoted, so no live price, statistics or chart can be shown. The congressional trades disclosed for it are listed below.

Congressional Trading Activity for AZNCF

1 transactions
Compliance: 100%
Michael K. Simpson18 Mar 201415 Apr 2014SaleStock$1,001 - $15,000N/A

Stock Overview

Market Data

Market Cap

$294.4B

Volume

1.43M

Beta

0.19

P/E Ratio

31.49

Fundamentals

EPS

$6.03

Div. Yield

1.38%

Open

$192.28

Day Range

$189.43 – $193.65

Company Information

Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
OTC · USD
Country
GB
CEO
Pascal Claude Roland Soriot
IPO Date
2009-02-13
Website
www.astrazeneca.com

AstraZeneca PLC functions as a global biopharmaceutical enterprise, committed to the entire process of pharmaceutical innovation, spanning from the initial discovery and development stages to the manufacturing and market introduction of its prescript...

Earnings

Recent Quarters

Q3 20256 Nov
EPS$2.38
Beat 3.9%
Q2 202529 Jul
EPS$2.17
Beat 0.5%
Q1 202529 Apr
EPS$2.49
Beat 10.7%
Q4 20246 Feb
EPS$2.09
Beat 1.0%
Q3 202412 Nov
EPS$2.08
Beat 2.0%
Q2 202425 Jul
EPS$1.98
Beat 0.5%
Q1 202425 Apr
EPS$2.06
Beat 7.8%
Q4 20238 Feb
EPS$1.45
Miss 0.7%
Q3 20239 Nov
EPS$1.73
Beat 2.4%
Q2 202328 Jul
EPS$2.15
Beat 8.6%
Q1 202327 Apr
EPS$1.92
Beat 12.3%
Q4 20229 Feb
EPS$1.38
Beat 3.0%
Q3 202210 Nov
EPS$1.67
Beat 9.2%
Q2 202229 Jul
EPS$1.72
Beat 9.6%
Q1 202229 Apr
EPS$1.89
Beat 10.5%
Q4 202110 Feb
EPS$1.67
Beat 7.7%
Q3 202112 Nov
EPS$1.08
Miss 15.6%
Q2 202129 Jul
EPS$0.90
Miss 1.1%
Q1 202130 Apr
EPS$1.63
Beat 9.4%
Q4 202011 Feb
EPS$1.07
Miss 13.7%
Q3 20205 Nov
EPS$0.94
Miss 1.1%
Q2 202031 Jul
EPS$0.96
Beat 6.7%
Q1 202029 Apr
EPS$1.05
Beat 16.7%
Q4 201914 Feb
EPS$0.89
Miss 11.9%
Q3 201924 Oct
EPS$0.99
Beat 3.1%
Q2 201925 Jul
EPS$0.73
Beat 15.9%
Q1 201926 Apr
EPS$0.89
Beat 3.5%
Q4 201814 Feb
EPS$1.58
Beat 7.5%
Q3 20188 Nov
EPS$0.71
Beat 2.9%
Q2 201826 Jul
EPS$0.69
Beat 1.5%
Q1 201818 May
EPS$0.48
Miss 20.0%
Q4 20172 Feb
EPS$1.30
Beat 52.9%
Q3 20179 Nov
EPS$1.12
Beat 2.8%
Q2 201727 Jul
EPS$0.87
Beat 10.1%
Q1 201727 Apr
EPS$0.99
Beat 22.2%
Q4 20162 Feb
EPS$1.21
Beat 5.2%
Q3 201610 Nov
EPS$1.32
Beat 33.3%
Q2 201628 Jul
EPS$0.83
Beat 0.0%
Q1 201629 Apr
EPS$0.95
Beat 2.1%
Q4 20154 Feb
EPS$0.94
Miss 1.1%
Q3 20155 Nov
EPS$1.03
Beat 0.0%
Q2 201530 Jul
EPS$1.20
Beat 15.4%
Q1 201524 Apr
EPS$1.08
Beat 1.9%
Q4 20145 Feb
EPS$0.76
Miss 7.3%
Q3 20146 Nov
EPS$1.05
Beat 4.0%
Q1 201424 Apr
EPS$0.40
Q4 201320 Mar
EPS$-0.42
Q4 201225 Mar
EPS$1.22
Q4 201128 Mar
EPS$1.16
Q2 20112 Aug
EPS$1.53
Q3 20102 Nov
EPS$1.08
Q4 200925 Mar
EPS$1.07
Q4 200817 Mar
EPS$0.86
Q4 200712 Mar
EPS$0.86
Q4 20066 Feb
EPS$0.93
Q2 20064 Aug
EPS$1.02
Q4 20056 Feb
EPS$0.77
Q3 20058 Nov
EPS$0.75
Q2 20055 Aug
EPS$0.75
Q1 200510 May
EPS$0.63
Q4 200421 Mar
EPS$0.65
Q2 200410 Aug
EPS$0.48
Q1 200419 May
EPS$47.00
Q4 200312 Mar
EPS$0.37
Q4 200225 Mar
EPS$0.25

Dividends

Dividend History

7 Aug 2026
Amount $1.0600
20 Feb 2026
Amount $2.1700
8 Aug 2025
Amount $0.5150
21 Feb 2025
Amount $2.1150
9 Aug 2024
Amount $0.9850
22 Feb 2024
Amount $1.9710
10 Aug 2023
Amount $0.9130
23 Feb 2023
Amount $1.9610
11 Aug 2022
Amount $0.9330
24 Feb 2022
Amount $1.9680
12 Aug 2021
Amount $0.8990
25 Feb 2021
Amount $1.9430
13 Aug 2020
Amount $0.9070
27 Feb 2020
Amount $1.8890
8 Aug 2019
Amount $0.8730
28 Feb 2019
Amount $1.9540
9 Aug 2018
Amount $0.8810
15 Feb 2018
Amount $1.8700
10 Aug 2017
Amount $0.8960
16 Feb 2017
Amount $1.8720
11 Aug 2016
Amount $0.8903
18 Feb 2016
Amount $2.0810
13 Aug 2015
Amount $0.9970
19 Feb 2015
Amount $2.1440
13 Aug 2014
Amount $0.9920
19 Feb 2014
Amount $2.1110
14 Aug 2013
Amount $0.9194
13 Feb 2013
Amount $2.1111
8 Aug 2012
Amount $0.9097
15 Feb 2012
Amount $2.1667
3 Aug 2011
Amount $0.9444
2 Feb 2011
Amount $2.0556
4 Aug 2010
Amount $0.7778
3 Feb 2010
Amount $1.9000
5 Aug 2009
Amount $0.6556

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about AZNCF

Which members of Congress have traded AZNCF?
1 member of Congress has disclosed 1 trade in AstraZeneca PLC (AZNCF) under the STOCK Act: Michael K. Simpson.
When was AZNCF most recently disclosed by Congress?
The most recent AZNCF disclosure was a sale by Michael K. Simpson on 18 March 2014.
What is the total disclosed congressional trading volume for AZNCF?
Members of Congress have disclosed approximately $8K in AZNCF sales (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in AZNCF?
This AZNCF page updates as soon as new STOCK Act disclosures are filed for AstraZeneca PLC. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.